Aggressive skin cancers in a cardiac transplant recipient

Australasian Radiology

Volumn 41, Issue 4, 1997, Pages 363-366

  Veness, M J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Cardiac transplant; Merkel cell carcinoma; Skin cancer

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CASE REPORT; HEART TRANSPLANTATION; HUMAN; MAINTENANCE THERAPY; MALE; MERKEL CELL TUMOR; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; SKIN CANCER; TUMOR LOCALIZATION;

EID: 0030731494     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.1997.tb00734.x     Document Type: Article

References (16)

1. O'Connell JB, Bourge RC, Costanzo-Nordin MR et al. Cardiac transplantation: Recipient selection, donor procurement, and medical follow up. Circulation 1992; 86: 1061-79.
2. Veness MJ, Quinn DI, Keogh A et al. Malignancies following cardiothoracic transplantation. 47th AGSM, Perth. The Royal Australasian College of Radiologists. Programme and Book of Abstracts 1996; 243.
3. Penn I, Hammond W, Brettschneider L et al. Malignant lymphomas in transplantation patients. Transplant. Proc. 1969; 1: 106-12.
4. Marks R, Staples M, Giles G. Trends in non-melanocytic skin cancer treated in Australia: The second national survey. Int. J. Cancer 1993; 53: 585-90.
5. Couetil J, McGoldrick J, Wallwork J et al. Malignant tumors after heart transplantation. J. Heart Lung Transplant. 1990; 9: 622-6.
6. Sheil AG, Disney A, Mathew T et al. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant. Proc. 1993; 25: 1383-4.
7. Penn I. Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant. Proc. 1996; 28: 876-8.
8. Bouwes-Bavinck JN, Robertson I, Wainwright R et al. Excessive numbers of skin cancers and pre-malignant skin lesions in an Australian heart transplant recipient. Br. Heart J. 1995; 74: 468-70.
9. Penn I. Malignancy. Surg. Clin. North Am. 1994; 74: 1247-57.
10. Starzl TE, Nalesnik MA, Porter KA et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984; 1: 583-7.
11. Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine carcinoma of the skin: A clinicopathologic and ultrastructural study of 43 cases. Am. J. Surg. Pathol. 1985; 9: 95-108.
12. Pacella J, Ashby M, Ainslie J et al. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors (Merkel cell or trabecular carcinoma): Experience at the Peter MacCallum Cancer Institute (Melbourne, Australia). Int. J. Radiat. Oncol. Biol. Phys. 1988; 14: 1077-84.
13. Stempfle HU, Mudra H, Angermann C et al. Rapid growth of cutaneous neuroendocrine (Merkel cell) carcinoma during treatment of refractory cardiac allograft rejection with OKT 3 monoclonal antibody. J. Heart Lung Transplant. 1993; 12: 501-3.
14. Swinnen LJ, Costanzo-Nordin, Fischer S et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT 3 in cardiac-transplant recipients. N. Engl. J. Med. 1990; 323: 1723-8.
15. Barr BB, Benton EC, McLaren K et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989; 1: 124-9.
16. Trush E, Mimnaugh E, Gram T. Activation of pharmacological agents to radical intermediates. Implications for the role of free radicals in drug action and toxicity. Biochem. Pharmacol. 1982; 31: 3335-46.